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strated that 9 of 24 (38%) 
SCS insertions were suc-
cessful, compared with 3 
of 26 (12%) reoperations 
(P=.04; number needed to 
treat=3.8).
Low back pain shows 
signiﬁ cant response 
to stimulation
A 2004 systematic review of 
SCS for all indications in-
cluded 51 studies and 2973 
patients.2 Sixteen of the 
studies, with a total of 616 
patients, focused on low back pain, specifi cally 
chronic back pain and failed back surgery syn-
drome. Two of the 16 studies were prospective 
controlled trials, 8 were prospective trials with-
out controls, and 6 were retrospective studies. 
Both prospective, controlled trials (total of 
62 patients) demonstrated statistically signifi -
cant (P<.05) results with SCS. One measured 
subjective pain and the other used crossover 
to the other treatment arm (SCS vs surgery) as 
a marker for treatment failure.
Consider the side effects
SCS isn’t without side eff ects. Cameron’s 
systematic review of 51 SCS studies reported 
rates for a number of complications (TABLE).2 
Th e most common complication was lead 
migration—displacement of the spinal elec-
trodes that can cause pain to recur. 
Recommendations
Evidence-based guidelines for interventional 
techniques to control chronic pain, published 
 When should you consider 
implanted nerve stimulators for 
lower back pain?
EVIDENCE-BASED ANSWER
A consider it for patients with failed back  surgery syndrome. Th ese patients can gain more 
pain relief from spinal cord stimulation (SCS) than from reop-
eration (strength of recommendation [SOR]: A, 2 randomized 
controlled trials [RCTs]). SCS can also treat chronic low back 
pain eff ectively (SOR: B, cohort studies). It’s indicated when 
conservative measures have failed (SOR: C, expert opinion). 
Th e side eff ects and failure rates of SCS are well docu-
mented and should be considered before recommending 
the therapy to patients (SOR: A, systematic review of RCTs 
and cohort studies).
Evidence summary
SCS systems comprise transcutaneously in-
serted leads that deliver low-voltage electron-
ic stimulation to the spinal cord or targeted 
peripheral nerves. Th e resulting dermatomal 
parasthesia can be preferable to chronic pain-
ful stimuli. Th e voltage generator is located 
externally or implanted internally. 
SCS can be used to treat patients with 
chronic and intractable pain, such as the pain 
caused by failed back surgery syndrome. Th e 
syndrome, defi ned as persistent or recurrent 
pain after lumbosacral spine surgery, occurs 
in 10% to 40% of patients who have undergone 
lumbosacral spine surgery.1 
A 2005 prospective RCT enrolled 50 pa-
tients with failed back surgery syndrome who 
were considering reoperation.1 Twenty-four 
were randomized to SCS and 26 to reopera-
tion. Success was defi ned as >50% pain relief 
measured by a validated visual analog pain 
scale. Th e average length of follow-up was 
3 years. An intention-to-treat analysis demon-
Joshua R. Merok, MD, 
and Richard Guthmann, 
MD, MPH 
University of Illinois at 
Chicago/Illinois Masonic 
Family Practice Residency 
Program, Chicago
Amy Blevins, MALS
Laupus Health Sciences 
Library, East Carolina 
University, Greenville, NC
Spinal cord 
stimulation 
can relieve pain 
better than 
reoperation 
for patients 
with failed 
back surgery 
syndrome.
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in the January 2007 edition of Pain Physician, 
classify indications for SCS as follows:3
❚ Strong indication: complex regional 
pain syndrome (CRPS)
❚ Moderate indication: failed back sur-
gery syndrome, chronic low back pain, and 
chronic lower extremity pain.
Th e Society of British Neurological Sur-
geons lists the following conditions as “good 
indications” for SCS: failed back surgery 
syndrome, CRPS, neuropathic pain from pe-
ripheral nerve damage, pain secondary to pe-
ripheral vascular disease, refractory angina, 
and brachial plexopathy.4  
TABLE
Major complications of SCS
Complication Rate
Lead migration 13.2%
Lead breakage 9.1%
Infection 3.4%
Hardware malfunction 2.9%
Unwanted stimulation 2.4%
Battery failure 1.6%
Pain over implant 0.9%
SCS, spinal cord stimulation.
Adapted from: Cameron T, et al. J Neurosurg.2
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